Monashee Investment Management’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Monashee Investment Management’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-90,020	Closed	-$60K	–	169
2021 Q3	$60K	Sell	90,020 -9,978	-10%	-$9.59K	0.01%	196
2021 Q2	$152K	Hold	99,998	–	–	0.02%	292
2021 Q1	$169K	Buy	+99,998	New	+$203K	0.03%	258

Other funds holding APGNW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Monashee Investment Management's APGNW Position: Q4 2021 in Review

Monashee Investment Management sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q4 2021, closing a stake of 90,020 shares — an estimated $60K sold.

Monashee Investment Management first reported a position in APGNW in Q1 2021 and held it in 3 quarters. The position peaked at $169K in Q1 2021. 15 funds tracked by Wall St. Rank hold APGNW as of Q4 2021.

Monashee Investment Management reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
Monashee Investment Management sold 90,020 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q4 2021, an estimated $60K.
Monashee Investment Management first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 3 quarters.
Monashee Investment Management's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $169K in Q1 2021.
15 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q4 2021.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.